Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesPrognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort
Journal of Viral Hepatitis, 10/13/09
Thein HH et al. – The results indicate that rates of progression to advanced liver disease in post–transfusion cohorts may be lower than previously reported. The Canadian post–transfusion cohort offers new and relevant prognostic information for post–transfusion HCV patients in Canada and is an invaluable resource to study the natural history and resource utilization of HCV–infected individuals in future studies.
Related Articles
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 70%
Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C
World Journal of Gastroenterology, 10/30/09
Relevance Score: 70%
FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09
Relevance Score: 70%
Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial
Hepatology, 10/14/09
Relevance Score: 69%
The HLA-ER/HLA-ER Genotype Affects the Natural Course of Hepatitis C Virus (HCV) Infection and Is Associated with HLA-E–Restricted Recognition of an HCV-Derived Peptide by Interferon[gamma]–Secreting Human CD8+ T Cells
The Journal of Infectious Diseases, 10/14/09
Relevance Score: 69%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Screening for hepatitis B in chemotherapy patients: survey of current oncology practices
Alimentary Pharmacology and Therapeutics, 12/16/09
Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation
Transplantation Proceedings, 12/16/09
The Benefits of Interferon Treatment in Patients Without Sustained Viral Response After Living Donor Liver Transplantation for Hepatitis C
Transplantation Proceedings, 12/16/09
Article Search
Sponsor